Insiders Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Delayed Nasdaq Other stock markets 16:00:00 2024-06-18 EDT			5-day change	1st Jan Change
25.93 ^USD	-0.23%		+0.27%	+14.43%

05-30	Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics	CI
05-28	Anika Therapeutics Approves $40 Million Share Repurchase Program	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anika Therapeutics, Inc. Announces Board Changes	05-28	CI
Anika Therapeutics, Inc. Announces Management Changes, Effective June 3, 2024	05-08	CI
Anika Therapeutics, Inc. Announces Board Changes	02-26	CI
Anika Therapeutics, Inc. Appoints Anne Nunes as Senior Vice President, Chief Operations Officer	23-06-21	CI
Anika Therapeutics reaches settlement with activist investor Caligan	23-04-13	RE
Anika Therapeutics, Inc. Appoints Gary Fischetti as Class III Director	23-04-13	CI
Insider Buy: Anika Therapeutics	22-03-14	MT
Anika Appoints Sheryl Conley to Board of Directors	21-11-01	CI
Insider Trends: Insider Purchase of Anika Therapeutics Stock Extends 90-Day Positive Trend	21-08-13	MT
Insider Trends: 90-Day Insider Buying Trend at Anika Therapeutics Slowed with Sale of Shares	20-11-12	MT
Anika Therapeutics, Inc. Announces Board Changes	20-09-08	CI
Anika Therapeutics, Inc. Announces Executive Changes, Effective August 10, 2020	20-08-05	CI
Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Chief Financial Officer Effective August 21, 2020	20-06-02	CI
Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Treasurer and Assistant Secretary Effective August 21, 2020	20-06-02	CI
Anika Therapeutics, Inc. Appoints Cheryl R. Blanchard as President and Chief Executive Officer	20-04-27	CI
Anika Therapeutics, Inc. Appoints David Colleran as Executive Vice President, General Counsel and Corporate Secretary	20-03-04	CI
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO	20-02-12	CI
Anika Therapeutics, Inc. Announces Demise of Joseph Darling, President and Chief Executive Officer	20-01-29	CI
Anika Therapeutics, Inc. Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality and Clinical Affairs	19-10-14	CI
Anika Therapeutics, Inc. Appoints James Loerop as Executive Vice President of Business Development and Strategic Planning	19-07-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Insiders

Filters